BioNTech BNTX
$80.96 −$0.42 (-0.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.00 +0.05%
Open$80.82
Prev close$81.38
Day range$80.27 – $82.87
Volume1.71M
Market cap$20.07B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±3.8%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+4.1%
Worst reaction-17.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 3 Nov 2026 | None | ±8.4% | -0.70% | Within range |
| 2026/Q2 | 4 Aug 2026 | Pre Market | ±7.3% | -0.98% | Within range |
| 2026/Q1 | 5 May 2026 | Pre Market | ±7.4% | -3.88% | Within range |
| 2025/Q4 | 10 Mar 2026 | Pre Market | ±6.7% | -17.88% | Bigger than priced |
| 2025/Q3 | 3 Nov 2025 | Pre Market | ±7.1% | +0.04% | Within range |
| 2025/Q2 | 4 Aug 2025 | None | ±8.6% | +2.51% | Within range |
| 2025/Q1 | 5 May 2025 | Pre Market | ±10.7% | -3.66% | Within range |
| 2024/Q4 | 10 Mar 2025 | None | ±10.8% | -3.15% | Within range |
| 2024/Q3 | 4 Nov 2024 | Pre Market | ±9.5% | -2.25% | Within range |
| 2024/Q2 | 5 Aug 2024 | None | ±6.2% | -4.45% | Within range |
| 2024/Q1 | 6 May 2024 | None | ±6.4% | +0.68% | Within range |
| 2023/Q4 | 20 Mar 2024 | None | ±10.1% | -4.38% | Within range |
| 2023/Q3 | 6 Nov 2023 | Pre Market | ±8.6% | +4.10% | Within range |
| 2023/Q2 | 7 Aug 2023 | None | ±8.4% | -7.49% | Within range |
| 2023/Q1 | 8 May 2023 | None | ±7.2% | -0.35% | Within range |
| 2022/Q4 | 27 Mar 2023 | Pre Market | ±6.0% | -3.59% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€1.29B-15.1% YoY
Operating profit€138.10M-78.9% YoY
Net profit€184.50M+742.9% YoY
Diluted EPS€0.73+708.3% YoY
Free cash flow-€178.30M-124.0% YoY
Operating cash flow-€129.80M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin75.0%
Operating margin-72.7%
Net margin-60.9%
Return on equity-8.1%
Return on assets-7.1%
Return on invested capital-8.0%
Current ratio8.55
Liabilities / assets12.2%
Cash & investments€14.66B
Total debt€312.80M
Net cash (debt)€14.34B
No comments yet — be the first to weigh in on BNTX.
Sign in to join the discussion.